YU91101A - Antipsihoticni ciklicni n-aralkil amini - Google Patents

Antipsihoticni ciklicni n-aralkil amini

Info

Publication number
YU91101A
YU91101A YU91101A YUP91101A YU91101A YU 91101 A YU91101 A YU 91101A YU 91101 A YU91101 A YU 91101A YU P91101 A YUP91101 A YU P91101A YU 91101 A YU91101 A YU 91101A
Authority
YU
Yugoslavia
Prior art keywords
chlorine
hydrogen
compounds
fluorine atom
aralkyl amines
Prior art date
Application number
YU91101A
Other languages
English (en)
Inventor
Robert Boigegrain
Martine Bourrie
Pierre Lair
Raymond Paul
Martine Poncelet
Jean-Claude Vernieres
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of YU91101A publication Critical patent/YU91101A/sh
Publication of RS50266B publication Critical patent/RS50266B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Pronalazak se odnosi na jedinjenja formule (I), gde A, predstavlja grupu koja se bira izmedju sledećih grupa: -C≡C-; -CH=CH-; CH2-CH2-; n je jednako 1 ili 2; X predstavlja atom vodonika, hlora ili fluora, metil ili metoksi grupu; Y predstavlja atom vodonika, hlora ili fluora; R1 predstavlja cikloheksil, fenil, cikloheptil, tercijarni butil, diciklopropilmetil, biciklo[3.2.1]oktanil, 4-tetrahidropiranil, 4-tetraidrotiopiranil ili adamantil grupu; R2 i R3 grade zajedno sa atomom azota na koji su vezani ciklični amin; i na adicione soli pomenutih jedinjenja sa farmaceutski prihvatljivim kiselinama, isto kao i na njihove solvate i hidrate.
YU91101A 1999-07-02 2000-06-27 Antipsihotični ciklični n-aralkil amini RS50266B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908532A FR2795724B1 (fr) 1999-07-02 1999-07-02 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
YU91101A true YU91101A (sh) 2004-09-03
RS50266B RS50266B (sr) 2009-07-15

Family

ID=9547628

Country Status (31)

Country Link
US (1) US6908914B1 (sh)
EP (1) EP1196403B1 (sh)
JP (1) JP4931309B2 (sh)
KR (1) KR100760446B1 (sh)
CN (1) CN1156462C (sh)
AR (1) AR029374A1 (sh)
AT (1) ATE309231T1 (sh)
AU (1) AU778299B2 (sh)
BG (1) BG65209B1 (sh)
BR (1) BR0012463B1 (sh)
CA (1) CA2376691C (sh)
CO (1) CO5021196A1 (sh)
CZ (1) CZ300936B6 (sh)
DE (1) DE60023898T2 (sh)
DK (1) DK1196403T3 (sh)
EA (1) EA004048B1 (sh)
ES (1) ES2250160T3 (sh)
FR (1) FR2795724B1 (sh)
HK (1) HK1043122A1 (sh)
HR (1) HRP20010949B1 (sh)
HU (1) HU228983B1 (sh)
IL (2) IL147069A0 (sh)
ME (1) MEP25508A (sh)
MX (1) MXPA01013207A (sh)
NO (1) NO322230B1 (sh)
NZ (1) NZ516342A (sh)
RS (1) RS50266B (sh)
TW (1) TWI285640B (sh)
UA (1) UA71009C2 (sh)
WO (1) WO2001002380A1 (sh)
ZA (1) ZA200200018B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1420644B1 (de) * 2001-08-23 2006-05-31 Bayer CropScience S.A. Substituierte propargylamine
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790971A (fr) * 1971-11-09 1973-05-07 Janssen Pharmaceutica Nv Metode ter voorkoming van patologische reakties die de funktie van het komplement vereisen
JPS504086A (sh) * 1973-01-18 1975-01-16
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
US4912222A (en) * 1988-06-17 1990-03-27 Fisons Corporation Antihistamines related to cyproheptadine
EP0347123A3 (en) * 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
US4855462A (en) * 1988-06-17 1989-08-08 Pennwalt Corporation Antihistamines
FR2663328B1 (fr) * 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
JPH06509069A (ja) * 1991-06-27 1994-10-13 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンドおよびその用途
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
US5486517A (en) * 1994-05-10 1996-01-23 Warner-Lambert Company Benzimidazoles and imidazopyridines as central nervous system agents
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
TR199902283T2 (xx) * 1997-03-18 1999-12-21 Smithkline Beecham P.L.C. �kame edilmi� izokuinolin t�revleri ve bunlar�n antikonvulsant olarak kullan�m�.

Also Published As

Publication number Publication date
JP2003503487A (ja) 2003-01-28
TWI285640B (en) 2007-08-21
CZ300936B6 (cs) 2009-09-16
IL147069A (en) 2006-09-05
EP1196403A1 (fr) 2002-04-17
MEP25508A (en) 2010-06-10
NO20016392D0 (no) 2001-12-27
WO2001002380A1 (fr) 2001-01-11
ATE309231T1 (de) 2005-11-15
AU5992400A (en) 2001-01-22
IL147069A0 (en) 2002-08-14
CN1156462C (zh) 2004-07-07
PL356186A1 (en) 2004-06-14
NO322230B1 (no) 2006-08-28
HK1043122A1 (zh) 2002-09-06
ZA200200018B (en) 2003-01-02
NZ516342A (en) 2003-08-29
FR2795724A1 (fr) 2001-01-05
ES2250160T3 (es) 2006-04-16
UA71009C2 (uk) 2004-11-15
HU228983B1 (en) 2013-07-29
RS50266B (sr) 2009-07-15
KR20020016877A (ko) 2002-03-06
CA2376691C (en) 2009-09-01
DE60023898D1 (de) 2005-12-15
WO2001002380A8 (fr) 2001-06-28
CN1367783A (zh) 2002-09-04
DE60023898T2 (de) 2006-08-10
CA2376691A1 (en) 2001-01-11
NO20016392L (no) 2002-03-04
EP1196403B1 (fr) 2005-11-09
BG65209B1 (bg) 2007-07-31
US6908914B1 (en) 2005-06-21
BR0012463B1 (pt) 2014-11-04
EA200101209A1 (ru) 2002-06-27
JP4931309B2 (ja) 2012-05-16
BG106255A (en) 2002-10-31
KR100760446B1 (ko) 2007-10-04
CZ20014697A3 (cs) 2002-04-17
FR2795724B1 (fr) 2002-12-13
HRP20010949B1 (en) 2006-06-30
HUP0202200A2 (en) 2002-10-28
BR0012463A (pt) 2002-04-02
CO5021196A1 (es) 2001-03-27
HUP0202200A3 (en) 2002-12-28
MXPA01013207A (es) 2002-06-21
AR029374A1 (es) 2003-06-25
DK1196403T3 (da) 2006-03-20
AU778299B2 (en) 2004-11-25
EA004048B1 (ru) 2003-12-25
HRP20010949A2 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
HRP20070529T3 (en) Imidazole derivatives as glutmate receptor antagonists
EP1468990A4 (en) piperazine derivative
MEP61208A (en) Novel compounds having inhibitory activity against sodium-dependant transporter
RS50980B (sr) Derivati n-hidroksiamida i njihova upotreba
WO2003059880A1 (fr) Derive d'amino-alcool ou derive d'acide phosphonique et composition medicamenteuse les contenant
YU91101A (sh) Antipsihoticni ciklicni n-aralkil amini
DE60130658D1 (de) Tnf-alpha-produktions-inhibitoren
CO5611152A2 (es) Compuestos derivados piperidina caracterizados por ser antagonistas del receptor de las taquicininas, especialmente del receptor nk1 y composiciones farmaceuticas que los contienen
EP1295608A4 (en) THERAPEUTIC FOR TREATING ANXIETY NEWROSES OR DEPRESSION THAT ALSO CONTAINS A PIPERAZINE DERIVATIVE
WO2002024623A3 (en) Novel alkanoic acid derivatives
EP1721906A4 (en) METHYLCEPHEM COMPOUND 3-PYRIDINIUM
MXPA04002569A (es) H6,7-dihidro-5h-pirazolo[1,2-a]pirazol-1-onas espirociclicas que controlan citocinas inflamatorias.
HUP0303186A2 (hu) 4-Amino-benzopirán-származékok
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren
EA200200611A1 (ru) Новые тетрагидропиридины, способ их получения и содержащие их фармацевтические композиции
WO2005061475A3 (en) Ornithine derivatives as prostaglandin e2 agonists or antagonists
ATE291928T1 (de) Oberflächenaktive verbindungen
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
RS50210B (sr) Derivati (1-fenaci-3-fenil-3-piperidiletil) piperidina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
DE69008069T2 (de) Antipsychotische Verbindungen.
RS51957B (en) N-HYDROXIAMIDE DERIVATIVES AND THEIR USE
EA200101204A1 (ru) Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции
YU78001A (sh) Derivati 6-(((aril i heteroaril)oksi)metil) naftalen-2- karboksimidamida, njihovo dobijanje i terapeutska primena
RS51467B (sr) Prolekovi za ligande nmda receptora
ATE455098T1 (de) Prostaglandin-derivate